Dexcom Aktie
Dexcom-Aktie
WKN: A0D9T1
ISIN: US2521311074
Land: USA
Branche: Chemie, Pharma, Bio- und Medizintechnik
Sektor: Medizintechnik
aktueller Kurs:
128,69 EUR
Veränderung:
-0,23 EUR
Veränderung in %:
-0,18 %
Komplette Navigation anzeigen

Dexcom Schedules First Quarter 2020 Earnings Release and Conference Call for April 28, 2020 at 4:30 p.m. Eastern Time

Donnerstag, 02.04.20 14:30
LED Tafel an Außenbereich eines Gebäudes
Bildquelle: iStock by Getty Images

SAN DIEGO –

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2020 financial results after market close on Tuesday, April 28, 2020. Management will hold a conference call to review the company's first quarter 2020 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to “About Us,” then “Investor Relations,” and then “Events and Presentations,” and will be archived there for future reference.

To listen to the conference call, please dial (800) 447-0521 (US/Canada) or (847) 413-3238 (International) and use the confirmation number "49260063" approximately five minutes prior to the start time.

About DexCom, Inc.

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.

Quelle: Business Wire



boerse.de-Aktienbrief

Investieren in die besten Aktien der Welt

Der Grundstein für den langfristigen Börsen-Erfolg wird durch die Wahl der richtigen Aktien gelegt! Dabei gilt es aus den weltweit zigtausend börsennotierten Werten jene herauszufiltern, die das investierte Kapital dauerhaft vermehren. Der boerse.de-Aktienbrief identifiziert genau diese Aktien und gibt dazu konkrete Kaufempfehlungen. Überzeugen Sie sich selbst mit zwei unverbindlichen und kostenlosen Ausgaben!